Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,408 | 173 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $807.18 | 13 | $0 (2024) |
| ABBVIE INC. | $675.25 | 22 | $0 (2024) |
| Dexcom, Inc. | $552.90 | 13 | $0 (2024) |
| Novo Nordisk Inc | $449.97 | 14 | $0 (2024) |
| PFIZER INC. | $354.80 | 27 | $0 (2024) |
| Lilly USA, LLC | $274.46 | 15 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $251.67 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $239.58 | 13 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $174.35 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $147.98 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,196 | 69 | AstraZeneca Pharmaceuticals LP ($455.91) |
| 2023 | $1,435 | 46 | IDORSIA PHARMACEUTICALS US INC ($251.67) |
| 2022 | $859.99 | 17 | AstraZeneca Pharmaceuticals LP ($212.04) |
| 2021 | $916.23 | 41 | PFIZER INC. ($149.45) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Biological | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $81.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $90.86 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $108.21 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $49.19 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Organon Llc | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: ETONOGESTREL AND ETHINYL ESTRADIOL | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $59.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $105.60 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.40 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Endocrinology | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 371 | 464 | $118,867 | $30,119 |
| 2022 | 7 | 362 | 499 | $102,349 | $25,090 |
| 2021 | 10 | 627 | 761 | $133,507 | $33,654 |
| 2020 | 6 | 356 | 456 | $89,409 | $18,601 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 174 | $54,502 | $12,124 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $21,310 | $6,558 | 30.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 66 | 67 | $16,878 | $4,393 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 85 | $18,067 | $4,044 | 22.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $4,758 | $1,870 | 39.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,863 | $796.77 | 42.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,388 | $308.80 | 22.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 11 | $101.64 | $24.20 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 169 | $52,936 | $11,454 | 21.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $14,207 | $4,531 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 95 | $20,192 | $4,495 | 22.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 45 | 46 | $11,588 | $2,882 | 24.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 14 | $1,330 | $956.28 | 71.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 15 | $1,035 | $426.28 | 41.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 77 | 118 | $1,062 | $344.36 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 201 | $62,959 | $14,560 | 23.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 92 | 108 | $22,955 | $4,924 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 46 | 46 | $15,560 | $4,844 | 31.1% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 159 | 159 | $8,730 | $2,891 | 33.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 47 | 49 | $12,344 | $2,466 | 20.0% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 67 | 67 | $6,115 | $2,054 | 33.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $1,235 | $844.10 | 68.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 22 | 22 | $1,905 | $597.74 | 31.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 57 | 82 | $738.00 | $243.00 | 32.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $966.00 | $230.33 | 23.8% |
About Tracy Kramer, N.P
Tracy Kramer, N.P is a Family healthcare provider based in Waco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548371438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tracy Kramer, N.P has received a total of $5,408 in payments from pharmaceutical and medical device companies, with $2,196 received in 2024. These payments were reported across 173 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,408).
As a Medicare-enrolled provider, Kramer has provided services to 1,716 Medicare beneficiaries, totaling 2,180 services with total Medicare billing of $107,464. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Waco, TX
- Active Since 08/31/2006
- Last Updated 01/06/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1548371438
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $474.71
- QULIPTA (Drug) $318.50
- FARXIGA (Drug) $302.18
- Wegovy (Drug) $287.54
- QUVIVIQ (Drug) $251.67
- BREZTRI (Drug) $226.41
- VRAYLAR (Drug) $223.43
- AIRSUPRA (Drug) $181.16
- VOQUEZNA (Drug) $174.35
- AREXVY (Drug) $151.12
- Kerendia (Drug) $147.98
- Veozah (Drug) $143.58
- Cologuard Collection Kit (Device) $135.67
- UBRELVY (Drug) $133.32
- ELIQUIS (Drug) $119.82
- Seglentis (Drug) $116.03
- INSPIRE (Device) $113.68
- NEXLIZET (Drug) $109.30
- RYBELSUS (Drug) $105.69
- TEZSPIRE (Biological) $97.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Waco
Jena Mann, Fnp-C, FNP-C
Family — Payments: $36,987
Leslie Muenzler, Np-C, NP-C
Family — Payments: $8,651
Jessica Dine, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $6,249
Jolene Donald, Fnp, FNP
Family — Payments: $5,804
Kendall Nobles, Fnp, FNP
Family — Payments: $5,165
Siovhan Grant
Family — Payments: $4,628